The role of miR-3654 in dysregulating glucose and lipid metabolism in polycystic ovary syndrome through SLC2A1
Abstract Objectives Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder. This study aimed to evaluate the diagnostic potential of microRNA-3654 (miR-3654) in PCOS and to elucidate its biological function in an in vitro model. Methods Serum expression levels of miR-3654 and solute carrier family 2 member 1 ( SLC2A1 ) were detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR) in 85 patients with PCOS and 85 control subjects. The correlation between miR-3654 levels and luteinizing hormone (LH) was assessed via Pearson correlation analysis. Then, the interaction between miR-3654 and SLC2A1 was verified by a dual-luciferase reporter assay. In addition, RT-qPCR, Western blot, and commercial kits were used to evaluate the effects of miR-3654 on glycolysis markers and key lipid metabolism factors mediated by SLC2A1 . Results Serum levels of miR-3654 were significantly upregulated in patients with PCOS (n=85, p<0.001), with a ROC curve AUC of 0.8127 (p<0.001). Its expression was positively correlated with LH (r=0.6839, p<0.0001) in PCOS patients. In testosterone-induced KGN (T-KGN) cells, miR-3654 inhibition significantly restored HK2 and LDHA expression (both p<0.001), enhanced lactate production (p<0.001), reduced pyruvate accumulation (p<0.001), and upregulated PPARγ , PGC-1α , and HMGCR (all p<0.001). SLC2A1 expression was significantly downregulated in both PCOS patients (p<0.001) and T-KGN cells (p<0.001). Crucially, the metabolic effects resulting from miR-3654 inhibition were reversed when SLC2A1 expression was concurrently suppressed (all p<0.05). Conclusions MiR-3654 held promise as a diagnostic biomarker for PCOS. Mechanistically, miR-3654 negatively targeted and regulated SLC2A1 , thereby disrupting glycolytic and lipid metabolic homeostasis in ovarian granulosa cells and contributing to the glycolipid metabolic disorders observed in PCOS.
Authors
- Xiaoqing Zhu (ORCID: https://orcid.org/0009-0003-6175-7437)
- Jing Bai (ORCID: https://orcid.org/0009-0008-9014-816X)
- Lulu Wang (ORCID: https://orcid.org/0009-0006-7317-1910)
Institutions
- China Three Gorges University (CN)
- Yichang Central People's Hospital (CN)
Publication Details
- Journal
- Turkish Journal of Biochemistry
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1515/tjb-2026-0037
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00